Tubal pregnancy and fertility
Treatment with the drug methotrexate to end a tubal pregnancy does not appear to have any significant impact on future fertility.
Advertisement
Treatment with the drug methotrexate to end a tubal pregnancy does not appear to have any significant impact on future fertility.A fertilised egg that implants in the fallopian tubes instead of the womb may present as an emergency. Ectopic pregnancy, as the condition is called, can be dealt with surgically or by medical drug treatment. Medical management of ectopic pregnancy is an alternative to surgical strategy, and has a good fertility rate.Researchers from the Antoine Beclere Hospital in Clamart, France, said that early detection of tubal pregnancy leads to less invasive and non-surgical methods of treatment. To look at the effect a methotrexate-based approach has on the subsequent chances of pregnancy, the researchers conducted a follow-up survey of 126 patients who were given methotrexate to treat an ectopic pregnancy. Of the 93 women who attempted to conceive, 76 (82 percent) became pregnant. A total of 64 pregnancies were spontaneous and 12 were the result of in vitro fertilization. Fifty-two of the unassisted pregnancies occurred within the uterus, but 12 of these resulted in miscarriages. The other 12 women had another ectopic pregnancy. After taking into account various factors, the researchers found that failure to become pregnant was only linked to a history of infertility. Thus, they concluded that fertility depends more on the patient's previous medical history than on her treatment for ectopic pregnancy.
Fertility and Sterility,
August 2004
August 2004
DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.
Advertisement